About Dana-Farber Cancer Institute

Yawkey Center for Cancer Care building with 2019 logo

Yawkey Center for Cancer Care at Dana-Farber Cancer Institute

Since its founding in 1947, Dana-Farber Cancer Institute has been committed to reducing the burden of cancer for adults and children through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world.

Dana-Farber's equal commitment to research and patient care is unique among cancer centers and results in an extraordinary level of collaboration between scientists and clinicians, speeding the translation of laboratory discoveries into lifesaving treatments for patients all over the world.

The Institute employs over 4,000 people supporting more than 380,000 patient visits a year, is involved in more than 1,200 clinical trials annually, and is internationally renowned for its blending of research and clinical excellence. It has been the top ranked cancer center in New England by U.S. News and World Report for 19 consecutive years, and is the only hospital consistently ranked in the top five in the country for both adult and pediatric cancer care.

Dana-Farber clinicians

Dana-Farber is a principal teaching affiliate of Harvard Medical School and a founding member of the Dana-Farber/Harvard Cancer Center and the Center for AIDS Research at Harvard University. Dana-Farber faculty access resources and scientific expertise in highly specialized fields through the Institute's associations with the Harvard Stem Cell Institute, Harvard's NIH Clinical and Translational Science Center, and the Broad Institute of MIT and Harvard, a center of genomic research where several Dana-Farber faculty members have joint appointments.

Providing advanced training in cancer treatment and research for an international faculty, the Institute conducts community-based programs in cancer prevention, detection, and control throughout New England, and maintains joint programs with other Boston institutions affiliated with Harvard Medical School, including Brigham and Women's Hospital and Boston Children's Hospital.

Sign up for updates ›